TIPARP and lung carcinoma: It has been shown that PARP7 inhibition by RBN2397 induces the IFN response of lung cancer cells through the activation of nucleic acid sensing via the cGAS/STING pathway and the downstream Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway (24).